Visionary Leader in Drug Development and Bioanalysis
Driving Drug Development Forward
Innovation in Immuno-Oncology and Immunotoxicology
Regulatory Expertise and Strategic Leadership
Lean Six Sigma for Excellence in Execution
Mentorship and Team Development
Compliance and Quality Assurance
Shaping the Future of Bioanalytics
Dr. Andrew Macintyre
Fractional Chief Medical Officer & Strategic Bioanalytical and Translational Research Officer
Meet Andrew Macintyre:
A Visionary Leader in Drug Development and Bioanalysis
Innovative Drug Development and Bioanalysis
A Pioneer in Drug Development
Andrew has played a crucial role in advancing more than 30 drug development programs to late-stage clinical trials. His deep understanding of the complexities of therapeutic landscapes has made him a go-to expert for moving innovative treatments from the lab to the clinic. By leading bioanalytical operations globally, he has ensured that these advancements are delivered efficiently, bringing life-changing therapies closer to patients.
Innovation in Immuno-Oncology and Immunotoxicology
As a pioneer in Immuno-Oncology and Immunotoxicology, he has developed cutting-edge methods to assess immune responses in clinical trials, enabling the creation of more precise and effective treatments. This work is not just about finding cures but about enhancing the quality of life for those battling serious illnesses.
Regulatory Expertise and Strategic Leadership
Expert in Regulatory Affairs and Strategic Leadership
Navigating the complex world of regulatory approvals is no easy task, but he excels here too. Having authored and submitted numerous 510(k), IND, and BLA applications, he has secured approvals from the FDA and European regulatory bodies. His strategic leadership extends beyond regulatory affairs; he has managed key partnerships with CROs and pharmaceutical companies, building lasting relationships based on trust and mutual success.
Upholding the Highest Standards of Compliance and Quality Assurance
His contributions have transformed the field of bioanalytical science, particularly in global clinical programs. He continues to push the boundaries of what's possible, pioneering new approaches that accelerate the progress of Immuno-Oncology and other therapeutic areas. The vision is clear: to lead the way in precision medicine, ensuring that innovative treatments reach those who need them most.
Operational Excellence and Process Improvement
Commitment to Excellence through Lean Six Sigma
With a certification as a Black Belt Lean Six Sigma practitioner, he is dedicated to excellence in execution. Lean Six Sigma methodologies have been implemented under his guidance to streamline project delivery, improve operational efficiencies, and uphold the highest quality standards. This focus on process improvement has not only optimized bioanalytical operations but also significantly enhanced team performance.
Shaping the Future of Bioanalytics
His contributions have transformed the field of bioanalytical science, particularly in global clinical programs. He continues to push the boundaries of what's possible, pioneering new approaches that accelerate the progress of Immuno-Oncology and other therapeutic areas. The vision is clear: to lead the way in precision medicine, ensuring that innovative treatments reach those who need them most.
Mentoring the Next Generation of Innovators
His passion for mentorship is evident in his work. Committed to fostering growth and innovation within his teams, he empowers them to achieve exceptional bioanalytical outcomes. His guidance has been instrumental in driving operational success in both clinical and pre-clinical environments, setting the stage for the next generation of leaders in drug development.